Cerenome is a US-based CNS oncology company connecting precision diagnostics, targeted therapeutics, and patient data into an integrated central nervous system (CNS) oncology platform to improve how CNS cancers are detected, treated, and understood.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
What is Market Cap of Cerenome Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cerenome Inc. market cap is $17.65M.
What is the 52-week high for Cerenome Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cerenome Inc. 52 week high is $23.43 as of September 13, 2026.
What is the 52-week low for Cerenome Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cerenome Inc. 52 week low is $2.31 as of September 13, 2026.
What is Cerenome Inc. stock price today?
Cerenome Inc. stock price today is $2.33.
What was Cerenome Inc. stock price yesterday?
Cerenome Inc. stock price yesterday was $2.39.
What is the PE ratio of Cerenome Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cerenome Inc.'s P/E ratio is -0.53.
What is the Price-to-Book ratio of Cerenome Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cerenome Inc. P/B ratio is 3.1111.
What is the 50-day moving average of Cerenome Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cerenome Inc. 50-day moving average is $3.49.
